sample_id	singscore_F	singscore_M	ssgsea_F	ssgsea_M	delta_singscore	delta_ssgsea	title	status	submission_date	last_update_date	type	channel_count	source_name_ch1	organism_ch1	characteristics_ch1	characteristics_ch1.1	characteristics_ch1.2	characteristics_ch1.3	characteristics_ch1.4	treatment_protocol_ch1	growth_protocol_ch1	molecule_ch1	extract_protocol_ch1	label_ch1	label_protocol_ch1	taxid_ch1	hyb_protocol	scan_protocol	description	data_processing	platform_id	contact_name	contact_email	contact_laboratory	contact_department	contact_institute	contact_address	contact_city	contact_state	contact_zip/postal_code	contact_country	supplementary_file	data_row_count	age:ch1	disease state:ch1	er status:ch1	her2 status:ch1	tissue:ch1
GSM1071862	30.58103163	51.452375419999996	NA	NA	0.29460050713705943	0	brain_met_J3	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	brain metastasis	Homo sapiens	disease state: brain metastatic breast cancer	tissue: brain metastasis	er status: ER-	her2 status: Her2+	age: 51 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	J3	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071862/suppl/GSM1071862_J3.CEL.gz	61359	51 yr	brain metastatic breast cancer	ER-	Her2+	brain metastasis
GSM1071863	23.576525949999997	59.32360397000001	NA	NA	-0.07658647540868713	0	brain_met_BT25	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	brain metastasis	Homo sapiens	disease state: brain metastatic breast cancer	tissue: brain metastasis	er status: ER+	her2 status: Her2+	age: 52.8 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	BT25	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071863/suppl/GSM1071863_BT25.CEL.gz	61359	52.8 yr	brain metastatic breast cancer	ER+	Her2+	brain metastasis
GSM1071864	43.98460115	246.02774748	NA	NA	-1.0364522441376396	0	brain_met_J12	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	brain metastasis	Homo sapiens	disease state: brain metastatic breast cancer	tissue: brain metastasis	er status: ER-	her2 status: Her2+	age: 55.4 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	J12	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071864/suppl/GSM1071864_J12.CEL.gz	61359	55.4 yr	brain metastatic breast cancer	ER-	Her2+	brain metastasis
GSM1071865	76.55778068000001	95.11479438	NA	NA	1.802770345060862	0	brain_met_BT16	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	brain metastasis	Homo sapiens	disease state: brain metastatic breast cancer	tissue: brain metastasis	er status: ER-	her2 status: Her2+	age: 43.7 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	BT16	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071865/suppl/GSM1071865_BT16.CEL.gz	61359	43.7 yr	brain metastatic breast cancer	ER-	Her2+	brain metastasis
GSM1071866	26.994172120000002	126.47024019	NA	NA	-0.5867134156245463	0	brain_met_J8	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	brain metastasis	Homo sapiens	disease state: brain metastatic breast cancer	tissue: brain metastasis	er status: ER+	her2 status: Her2+	age: 42.6 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	J8	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071866/suppl/GSM1071866_J8.CEL.gz	61359	42.6 yr	brain metastatic breast cancer	ER+	Her2+	brain metastasis
GSM1071867	38.19258158	66.958998083	NA	NA	0.46367223984058475	0	brain_met_BT34	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	brain metastasis	Homo sapiens	disease state: brain metastatic breast cancer	tissue: brain metastasis	er status: ER+	her2 status: Her2+	age: 55.5 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	BT34	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071867/suppl/GSM1071867_BT34.CEL.gz	61359	55.5 yr	brain metastatic breast cancer	ER+	Her2+	brain metastasis
GSM1071868	48.374798925	108.6895399	NA	NA	0.4854859401785193	0	brain_met_J1	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	brain metastasis	Homo sapiens	disease state: brain metastatic breast cancer	tissue: brain metastasis	er status: ER-	her2 status: Her2+	age: 37.6 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	J1	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071868/suppl/GSM1071868_J1.CEL.gz	61359	37.6 yr	brain metastatic breast cancer	ER-	Her2+	brain metastasis
GSM1071869	82.69606424	58.985147361	NA	NA	2.4126985678125106	0	brain_met_BT11	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	brain metastasis	Homo sapiens	disease state: brain metastatic breast cancer	tissue: brain metastasis	er status: ER-	her2 status: Her2+	age: 71.7 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	BT11	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071869/suppl/GSM1071869_BT11.CEL.gz	61359	71.7 yr	brain metastatic breast cancer	ER-	Her2+	brain metastasis
GSM1071870	21.683850405	61.878125866	NA	NA	-0.1810485213441414	0	brain_met_J2	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	brain metastasis	Homo sapiens	disease state: brain metastatic breast cancer	tissue: brain metastasis	er status: ER-	her2 status: Her2+	age: 51.5 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	J2	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071870/suppl/GSM1071870_J2.CEL.gz	61359	51.5 yr	brain metastatic breast cancer	ER-	Her2+	brain metastasis
GSM1071871	61.39681871	230.48945677	NA	NA	-0.15296079312312827	0	brain_met_BT30	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	brain metastasis	Homo sapiens	disease state: brain metastatic breast cancer	tissue: brain metastasis	er status: ER-	her2 status: Her2+	age: 58.8 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	BT30	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071871/suppl/GSM1071871_BT30.CEL.gz	61359	58.8 yr	brain metastatic breast cancer	ER-	Her2+	brain metastasis
GSM1071872	21.501226025	81.90879651	NA	NA	-0.3837763708017248	0	brain_met_J4	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	brain metastasis	Homo sapiens	disease state: brain metastatic breast cancer	tissue: brain metastasis	er status: ER-	her2 status: Her2+	age: 43.2 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	J4	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071872/suppl/GSM1071872_J4.CEL.gz	61359	43.2 yr	brain metastatic breast cancer	ER-	Her2+	brain metastasis
GSM1071873	16.078491845000002	71.17522361	NA	NA	-0.507285452983175	0	brain_met_BT57	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	brain metastasis	Homo sapiens	disease state: brain metastatic breast cancer	tissue: brain metastasis	er status: ER-	her2 status: Her2+	age: 66 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	BT57	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071873/suppl/GSM1071873_BT57.CEL.gz	61359	66 yr	brain metastatic breast cancer	ER-	Her2+	brain metastasis
GSM1071874	11.810257295	79.58247683	NA	NA	-0.7686311797043367	0	brain_met_J5	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	brain metastasis	Homo sapiens	disease state: brain metastatic breast cancer	tissue: brain metastasis	er status: ER-	her2 status: Her2+	age: 40.7 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	J5	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071874/suppl/GSM1071874_J5.CEL.gz	61359	40.7 yr	brain metastatic breast cancer	ER-	Her2+	brain metastasis
GSM1071875	63.611523059999996	192.41132843	NA	NA	0.3109533956773945	0	brain_met_BT51	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	brain metastasis	Homo sapiens	disease state: brain metastatic breast cancer	tissue: brain metastasis	er status: ER-	her2 status: Her2+	age: 38.5 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	BT51	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071875/suppl/GSM1071875_BT51.CEL.gz	61359	38.5 yr	brain metastatic breast cancer	ER-	Her2+	brain metastasis
GSM1071876	8.718220453	151.00202237	NA	NA	-1.5940991051530002	0	brain_met_BT31	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	brain metastasis	Homo sapiens	disease state: brain metastatic breast cancer	tissue: brain metastasis	er status: ER-	her2 status: Her2+	age: 57.2 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	BT31	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071876/suppl/GSM1071876_BT31.CEL.gz	61359	57.2 yr	brain metastatic breast cancer	ER-	Her2+	brain metastasis
GSM1071877	31.32621012	216.71309538	NA	NA	-1.2832891834035538	0	brain_met_J7	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	brain metastasis	Homo sapiens	disease state: brain metastatic breast cancer	tissue: brain metastasis	er status: ER-	her2 status: Her2+	age: 49.1 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	J7	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071877/suppl/GSM1071877_J7.CEL.gz	61359	49.1 yr	brain metastatic breast cancer	ER-	Her2+	brain metastasis
GSM1071878	34.609468225	55.38662434	NA	NA	0.42568742460314235	0	brain_met_J10	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	brain metastasis	Homo sapiens	disease state: brain metastatic breast cancer	tissue: brain metastasis	er status: ER-	her2 status: Her2+	age: 43.6 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	J10	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071878/suppl/GSM1071878_J10.CEL.gz	61359	43.6 yr	brain metastatic breast cancer	ER-	Her2+	brain metastasis
GSM1071879	22.742521019999998	129.79500471	NA	NA	-0.7978711218502977	0	brain_met_J11	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	brain metastasis	Homo sapiens	disease state: brain metastatic breast cancer	tissue: brain metastasis	er status: ER-	her2 status: Her2+	age: 49.1 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	J11	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071879/suppl/GSM1071879_J11.CEL.gz	61359	49.1 yr	brain metastatic breast cancer	ER-	Her2+	brain metastasis
GSM1071880	45.720517195	417.33883719	NA	NA	-2.6315966218728675	0	brain_met_BT40	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	brain metastasis	Homo sapiens	disease state: brain metastatic breast cancer	tissue: brain metastasis	er status: ER+	her2 status: Her2+	age: 50.4 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	BT40	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071880/suppl/GSM1071880_BT40.CEL.gz	61359	50.4 yr	brain metastatic breast cancer	ER+	Her2+	brain metastasis
GSM1071881	42.428946005	308.27681097000004	NA	NA	-1.7080175109556643	0	breast_primary_MGH16	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	primary breast tumor	Homo sapiens	disease state: nonmetastatic breast cancer	tissue: primary breast tumor	er status: ER-	her2 status: Her2+	age: 51 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	MGH16	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071881/suppl/GSM1071881_MGH16.CEL.gz	61359	51 yr	nonmetastatic breast cancer	ER-	Her2+	primary breast tumor
GSM1071882	53.59881933	365.20363841	NA	NA	-1.7926463429834274	0	breast_primary_MGH42	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	primary breast tumor	Homo sapiens	disease state: nonmetastatic breast cancer	tissue: primary breast tumor	er status: ER+	her2 status: Her2+	age: 50 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	MGH42	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071882/suppl/GSM1071882_MGH42.CEL.gz	61359	50 yr	nonmetastatic breast cancer	ER+	Her2+	primary breast tumor
GSM1071883	66.041877005	101.648788739	NA	NA	1.2969496246691252	0	breast_primary_MGH46	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	primary breast tumor	Homo sapiens	disease state: nonmetastatic breast cancer	tissue: primary breast tumor	er status: ER-	her2 status: Her2+	age: 56 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	MGH46	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071883/suppl/GSM1071883_MGH46.CEL.gz	61359	56 yr	nonmetastatic breast cancer	ER-	Her2+	primary breast tumor
GSM1071884	39.29002051	29.215130717999998	NA	NA	0.8773503140602887	0	breast_primary_MGH133	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	primary breast tumor	Homo sapiens	disease state: nonmetastatic breast cancer	tissue: primary breast tumor	er status: ER-	her2 status: Her2+	age: 44 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	MGH133	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071884/suppl/GSM1071884_MGH133.CEL.gz	61359	44 yr	nonmetastatic breast cancer	ER-	Her2+	primary breast tumor
GSM1071885	50.00396892	287.56335859	NA	NA	-1.1877891297157017	0	breast_primary_MGH153	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	primary breast tumor	Homo sapiens	disease state: nonmetastatic breast cancer	tissue: primary breast tumor	er status: ER+	her2 status: Her2+	age: 46 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	MGH153	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071885/suppl/GSM1071885_MGH153.CEL.gz	61359	46 yr	nonmetastatic breast cancer	ER+	Her2+	primary breast tumor
GSM1071886	48.59783451	120.94563875	NA	NA	0.3755209947028848	0	breast_primary_MGH351	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	primary breast tumor	Homo sapiens	disease state: nonmetastatic breast cancer	tissue: primary breast tumor	er status: ER+	her2 status: Her2+	age: 54 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	MGH351	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071886/suppl/GSM1071886_MGH351.CEL.gz	61359	54 yr	nonmetastatic breast cancer	ER+	Her2+	primary breast tumor
GSM1071887	37.828804840000004	24.90913818	NA	NA	0.8578354394873359	0	breast_primary_MGH1104	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	primary breast tumor	Homo sapiens	disease state: nonmetastatic breast cancer	tissue: primary breast tumor	er status: ER-	her2 status: Her2+	age: 32 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	MGH1104	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071887/suppl/GSM1071887_MGH1104.CEL.gz	61359	32 yr	nonmetastatic breast cancer	ER-	Her2+	primary breast tumor
GSM1071888	19.7311956705	140.21780315	NA	NA	-1.025989897233569	0	breast_primary_MGH574	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	primary breast tumor	Homo sapiens	disease state: nonmetastatic breast cancer	tissue: primary breast tumor	er status: ER-	her2 status: Her2+	age: 73 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	MGH574	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071888/suppl/GSM1071888_MGH574.CEL.gz	61359	73 yr	nonmetastatic breast cancer	ER-	Her2+	primary breast tumor
GSM1071889	59.62272633	395.59068351	NA	NA	-1.8352333030176189	0	breast_primary_MGH434	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	primary breast tumor	Homo sapiens	disease state: nonmetastatic breast cancer	tissue: primary breast tumor	er status: ER-	her2 status: Her2+	age: 51 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	MGH434	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071889/suppl/GSM1071889_MGH434.CEL.gz	61359	51 yr	nonmetastatic breast cancer	ER-	Her2+	primary breast tumor
GSM1071890	88.08967474	231.92180762	NA	NA	0.9555320531929516	0	breast_primary_MGH450	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	primary breast tumor	Homo sapiens	disease state: nonmetastatic breast cancer	tissue: primary breast tumor	er status: ER-	her2 status: Her2+	age: 60 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	MGH450	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071890/suppl/GSM1071890_MGH450.CEL.gz	61359	60 yr	nonmetastatic breast cancer	ER-	Her2+	primary breast tumor
GSM1071891	20.063781655	32.13804487	NA	NA	0.040420979643750465	0	breast_primary_MGH421	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	primary breast tumor	Homo sapiens	disease state: nonmetastatic breast cancer	tissue: primary breast tumor	er status: ER-	her2 status: Her2+	age: 71 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	MGH421	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071891/suppl/GSM1071891_MGH421.CEL.gz	61359	71 yr	nonmetastatic breast cancer	ER-	Her2+	primary breast tumor
GSM1071892	16.50130566	75.21587526	NA	NA	-0.5288518459476949	0	breast_primary_MGH482	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	primary breast tumor	Homo sapiens	disease state: nonmetastatic breast cancer	tissue: primary breast tumor	er status: ER-	her2 status: Her2+	age: 66 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	MGH482	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071892/suppl/GSM1071892_MGH482.CEL.gz	61359	66 yr	nonmetastatic breast cancer	ER-	Her2+	primary breast tumor
GSM1071893	78.880569765	102.1158728	NA	NA	1.832271195601235	0	breast_primary_MGH963	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	primary breast tumor	Homo sapiens	disease state: nonmetastatic breast cancer	tissue: primary breast tumor	er status: ER-	her2 status: Her2+	age: 41 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	MGH963	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071893/suppl/GSM1071893_MGH963.CEL.gz	61359	41 yr	nonmetastatic breast cancer	ER-	Her2+	primary breast tumor
GSM1071894	97.186613215	233.99472533300002	NA	NA	1.3178752609765965	0	breast_primary_MGH455	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	primary breast tumor	Homo sapiens	disease state: nonmetastatic breast cancer	tissue: primary breast tumor	er status: ER-	her2 status: Her2+	age: 61 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	MGH455	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071894/suppl/GSM1071894_MGH455.CEL.gz	61359	61 yr	nonmetastatic breast cancer	ER-	Her2+	primary breast tumor
GSM1071895	62.688175495	152.5537927	NA	NA	0.6602387868520152	0	breast_primary_MGH1084	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	primary breast tumor	Homo sapiens	disease state: nonmetastatic breast cancer	tissue: primary breast tumor	er status: ER-	her2 status: Her2+	age: 57 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	MGH1084	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071895/suppl/GSM1071895_MGH1084.CEL.gz	61359	57 yr	nonmetastatic breast cancer	ER-	Her2+	primary breast tumor
GSM1071896	89.738377005	131.04410921	NA	NA	2.0071559173851385	0	breast_primary_MGH1038	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	primary breast tumor	Homo sapiens	disease state: nonmetastatic breast cancer	tissue: primary breast tumor	er status: ER-	her2 status: Her2+	age: 50 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	MGH1038	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071896/suppl/GSM1071896_MGH1038.CEL.gz	61359	50 yr	nonmetastatic breast cancer	ER-	Her2+	primary breast tumor
GSM1071897	48.28908484	115.96581584	NA	NA	0.4110289802902641	0	breast_primary_MGH1057	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	primary breast tumor	Homo sapiens	disease state: nonmetastatic breast cancer	tissue: primary breast tumor	er status: ER-	her2 status: Her2+	age: 47 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	MGH1057	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071897/suppl/GSM1071897_MGH1057.CEL.gz	61359	47 yr	nonmetastatic breast cancer	ER-	Her2+	primary breast tumor
GSM1071898	69.3682174	83.511967213	NA	NA	1.6134300731971942	0	breast_primary_MGH674	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	primary breast tumor	Homo sapiens	disease state: nonmetastatic breast cancer	tissue: primary breast tumor	er status: ER-	her2 status: Her2+	age: 53 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	MGH674	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071898/suppl/GSM1071898_MGH674.CEL.gz	61359	53 yr	nonmetastatic breast cancer	ER-	Her2+	primary breast tumor
GSM1071899	33.3657973	130.97389785	NA	NA	-0.3626395251080803	0	breast_primary_MGH1102	Public on Apr 24 2014	Jan 28 2013	Apr 24 2014	RNA	1	primary breast tumor	Homo sapiens	disease state: nonmetastatic breast cancer	tissue: primary breast tumor	er status: ER+	her2 status: Her2+	age: 51 yr	The 19 HER2+ breast cancer brain metastatic specimens were fresh-frozen biopsies obtained from the M.D. Anderson Cancer Center between 1998 and 2001. The HER2+ primary breast cancer specimens were fresh-frozen biopsies obtained from the Massachusetts General Hospital in 2006.	Not applicable.	total RNA	4,000–5,000 malignant epithelial cells were procured by laser capture microdissection using a PixCell IIe system (Molecular Devices, Mountain View, CA, USA) as described in PubMed ID: 19187537. Total RNA was isolated from captured cells using the PicoPure RNA isolation kit (Molecular Devices), then amplified by T7 RNA amplification (RiboAmp; Molecular Devices).	biotin	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	9606	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).	According to manufacturer's instructions (Affymetrix, Santa Clara, CA, USA). The scanner model used to scan the arrays was an Affymetrix GeneChip Scanner 3000-7G.	MGH1102	MAS5.0 as implemented by Bioconductor package simpleaffy, version 2.14.05.	GPL1352	Ben,S.,Wittner	wittner.ben@mgh.harvard.edu	Lawrence	Center for Cancer Research	Massachusetts General Hospital	149 13th Street	Boston	MA	02129	USA	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1071nnn/GSM1071899/suppl/GSM1071899_MGH1102.CEL.gz	61359	51 yr	nonmetastatic breast cancer	ER+	Her2+	primary breast tumor
